Non-invasive blood component measurement system

• US 20050267346A1
• Filed: 01/31/2005
• Published: 12/01/2005
• Est. Priority Date: 01/30/2004
• Status: Abandoned Application

• Current Assignee: 3Wave Optics, LLC
• Original Assignee: 3Wave Optics, LLC
• Inventors: Schwendeman, Erik J., Faber, Ralf T., Wang, Guangming
• Application Number:
  US11/048,005
• Publication Number:
  US 20050267346A1
• Time in Patent Office: Days
• US Class Current: 600/322
• CPC Class Codes: A61B 5/0059 using light, e.g. diagnosis by transillumination, diascopy, fluorescence A61B5/0093, A61B5/1455, A61B5/02416 and A61B5/0261 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: A61B 5/1455 using optical sensors, e.g. spectral photometrical oximeters

Abstract

Non-invasive, optical apparatus and methods for the direct measurement of hemoglobin derivatives and other analyte concentration levels in blood using diffuse reflection and transmission spectroscopy in the wavelength region 400-1350 nm which includes the transparent tissue window from approximately 610 to 1311 nanometers and, using diffuse reflection spectroscopy, the mid-infrared region from 4.3-12 microns in wavelength. Large area light collection techniques are utilized to provide a much larger pulsate signal than can be obtain with current sensor technology. Sensors used in separate or simultaneous precision measurements of both diffuse reflection and transmission, either separately or simultaneously, from pulsate, blood-perfused tissue for the subsequent determination of the blood analytes concentrations such as arterial blood oxygen saturation (SaO₂), carboxyhemoglobin (COHb), oxyhemoglobin (OHb), deoxyhemoglobin (dOHb), methemoglobin (metHb), water (H2O), hematocrit (HCT), glucose, cholesterol and proteins such as albumin and other analytes components.

Claims

1. Apparatus for the non-invasive, precision measurement of blood analytes concentration in pulsate, blood-perfused tissue comprising:

a source of a beam of interrogating electromagnetic radiation in the infrared region produceable in n selected bands, where n≧

2, where each band interacts selectively with one of the blood analytes when said interrogating beam is incident upon the tissue to produce a diffusely reflected beam of said incident interrogating light,

a detector positioned between said source of electromagnetic radiation and the tissue, said detector being sensitive to radiation in said IR range, and said detector being curved concavely with respect to said tissue to maximize the detection over a large light collection area and produce an output electrical signal corresponding to the energy of said diffusely reflected beam, and

an analyzer that receives said signals and processes them to produce a measure of the concentration level of the blood analytes.

2. The apparatus of claim 1 wherein said light source is in the mid-infrared wavelength region, about 5 microns to about 10 microns.

3. The apparatus of claim 1 wherein said analyzer utilizes a residual least squares curve fitting algorithm to fit the collected diffuse light signals from the said blood pulsate tissue to a curve and an iterative constituent-sequenced algorithm for correlating said diffuse collected light signals with a set of the blood constituents.

4. The apparatus of claim 1 wherein said apparatus further includes a visual display of said measured concentration levels.

5. The apparatus of claim 1 wherein said apparatus further comprises the means for storing said measured current concentration levels.

6. Apparatus for the non-invasive, precision measurement of blood analytes concentration in pulsate, blood-perfused tissue comprising:

a source of a beam of interrogating electromagnetic radiation in the visible and near IR range produceable in n selected bands, where n≧

2, where each band interacts selectively with one of the blood analytes where said interrogating beam is incident upon the tissue to produce both a diffusely reflected and a diffusely transmitted beam of said incident interrogating light,

a detector including a diffusely reflected light detector positioned on a first side of the tissue adjacent the light source, and a diffusely transmitted light detector positioned on the opposite side of the tissue from said light source, both said diffusely reflected and diffusely transmitted detectors being configured and positioned to collect, respectively, the diffusely reflected and diffusely transmitted light beams that have interacted with the tissue over a large collection area, each of said detectors producing an electrical signal corresponding to the energy of the diffused light so collected,

means for analyzing the output signals from said diffusely reflected and diffusely transmitted detectors; and

an analyzer that receives said signals and processes them to produce a measure of the concentration level of the blood analytes.

7. The apparatus of claim 6 wherein said detectors are curved concavely along a parabolic or ellipsoidal curvature that is concave with respect to the tissue.

8. The apparatus of claim 6 wherein said visible and near infrared light is in the range of approximately 400-1350 nm.

9. The apparatus of claim 8 wherein said visible and near infrared light is within the transparent tissue window from approximately 610 to 1311 nm.

10. The apparatus of claim 6 wherein said apparatus further includes a visual display of said measured concentration levels.

11. The apparatus according to claim 6 wherein said light source is selected from the group consisting of a quartz halogen lamp, a white light LED, discrete wavelength LED'"'"'s, or diode lasers.

12. The apparatus according to claim 11, wherein said light source includes a spectrometer operating in combination with sources emitting a spectral continuum of light in the visible and near IR to produce said n spectral bands.

13. The method of non-invasively measuring with precision blood analytes concentrations comprising the steps of:

illuminating pulsate, blood-perfused tissue with an interrogating beam of infrared radiation in the mid-IR range and in n spectral bands where n≧

2 and each band selectively interacts with a one of the analytes being measured,

detecting light diffusely reflected from said pulsate blood-perfused tissue wherein said detection is over a large collection area that is concavely curved with respect to the tissue and produces an output electrical signal corresponding to the intensity of the collected diffusely reflected light in each spectral band that in turn corresponds to the blood analyte concentration to be measured; and

analyzing said output signal of said detector to calculate the blood analyte concentration measurements.

14. The method according to claims 13 wherein said IR radiation region is in the mid-IR range and said analyzing utilizes a residual least squares curve fitting algorithm to fit the collected diffuse light signals from the said blood pulsate tissue to a curve and an iterative constituent-sequenced algorithm for correlating said diffuse collected light signals with a set of the blood constituents.

15. The method according to claim 13 wherein said analyzing collected light utilizes data over the full wavelength range of the interrogating IR beam.

16. The method of non-invasively measuring with precision blood analytes concentrations comprising the steps of:

illuminating pulsate, blood-perfused tissue with an interrogating beam of electromagnetic radiation in the visible and near IR range and in n spectral bands where n≧

2 and each band selectively interacts with one of the analytes being measured,

detecting light that is both diffusely reflected and diffusely transmitted from said pulsate blood-perfused tissue, said detection beam is over a large collection area that is concavely curved with respect to the tissue, and producing an output electrical signal corresponding to the intensity of the collected diffusely reflected light in each spectral band and, in turn, corresponding to the blood analyte concentration to be measured; and

analyzing said output signal of said detector to calculate the blood analyte concentration measurements.

17. The method according to claim 16 wherein said range is approximately 400 to 1350 nm.

18. The method according to claim 16 wherein said range is within the transparent tissue window of approximately 610 to 1311 nm.

19. The method of claim 16 wherein said concavely curved detection is selected from the group consisting of ellipsoidal and parabolic.